Jubilant Pharmova (BOM:530019) E10: ₹42.70 (As of Mar. 2026)


BOM:530019 Jubilant Pharmova Ltd BOM:530019
70 GF Score
Price ₹970.90
GF Value ₹1,055.61
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Jubilant Pharmova E10?

Jubilant Pharmova BOM:530019 -0.42% 70 E10 is ₹42.70 as of Mar. 2026. GuruFocus rates BOM:530019 with a GF Score™ of 70/100 and a GF Value™ of ₹1,055.61 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Jubilant Pharmova's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹7.520. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹42.70 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Jubilant Pharmova's average E10 Growth Rate was 0.70% per year. During the past 3 years, the average E10 Growth Rate was 6.00% per year. During the past 5 years, the average E10 Growth Rate was 15.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Jubilant Pharmova was 28.50% per year. The lowest was 6.00% per year. And the median was 18.65% per year.

As of today (2026-07-09), Jubilant Pharmova's current stock price is ₹970.90. Jubilant Pharmova's E10 for the quarter that ended in Mar. 2026 was ₹42.70. Jubilant Pharmova's Shiller PE Ratio of today is 22.74.

During the past 13 years, the highest Shiller PE Ratio of Jubilant Pharmova was 45.53. The lowest was 7.79. And the median was 22.61.


Jubilant Pharmova  (BOM:530019) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Jubilant Pharmova's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=970.90/42.70
=22.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Jubilant Pharmova was 45.53. The lowest was 7.79. And the median was 22.61.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Jubilant Pharmova E10 Related Terms


Jubilant Pharmova E10 Historical Data

* Premium members only.

The historical data trend for Jubilant Pharmova's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jubilant Pharmova E10 Chart

Jubilant Pharmova Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.85 35.83 36.70 42.40 42.70

Jubilant Pharmova Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.40 42.31 42.45 41.81 42.70

BOM:530019 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jubilant Pharmova's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jubilant Pharmova Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jubilant Pharmova's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Jubilant Pharmova's Shiller PE Ratio falls into.


BOM:530019
70GF Score
Jubilant Pharmova Ltd BOM:530019
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jubilant Pharmova E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jubilant Pharmova's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=7.52/164.2724*164.2724
=7.520

Current CPI (Mar. 2026) = 164.2724.

Jubilant Pharmova Quarterly Data

per share eps CPI Adj_EPS
201606 9.630 105.961 14.929
201609 9.290 105.961 14.402
201612 7.660 105.196 11.962
201703 9.630 105.196 15.038
201706 9.940 107.109 15.245
201709 8.230 109.021 12.401
201712 13.640 109.404 20.481
201803 9.940 109.786 14.873
201806 13.000 111.317 19.184
201809 13.500 115.142 19.260
201812 16.740 115.142 23.883
201903 -6.380 118.202 -8.867
201906 11.610 120.880 15.778
201909 15.660 123.175 20.885
201912 12.770 126.235 16.618
202003 16.350 124.705 21.538
202006 5.530 127.000 7.153
202009 14.060 130.118 17.751
202012 19.460 130.889 24.423
202103 13.430 131.771 16.743
202106 10.090 134.084 12.362
202109 8.970 135.847 10.847
202112 3.200 138.161 3.805
202203 3.740 138.822 4.426
202206 2.960 142.347 3.416
202209 0.340 144.661 0.386
202212 -0.980 145.763 -1.104
202303 -6.150 146.865 -6.879
202306 0.400 150.280 0.437
202309 3.940 151.492 4.272
202312 4.200 152.924 4.512
202403 -3.690 153.035 -3.961
202406 30.350 155.789 32.003
202409 6.460 157.882 6.721
202412 6.360 158.323 6.599
202503 9.680 157.552 10.093
202506 6.470 159.755 6.653
202509 7.570 162.289 7.663
202512 3.520 163.281 3.541
202603 7.520 164.272 7.520

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹42.70 mean?
Jubilant Pharmova (BOM:530019) has a E10 of ₹42.70 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jubilant Pharmova and its competitors.
Is Jubilant Pharmova's E10 too high?
Jubilant Pharmova's current E10 is ₹42.70. Overall, Jubilant Pharmova has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jubilant Pharmova's E10 compare to ZTS and UTHR?
Jubilant Pharmova's E10 of ₹42.70 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jubilant Pharmova and its competitors. Jubilant Pharmova's current E10 is ₹42.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jubilant Pharmova stock overvalued right now?
Based on GuruFocus' analysis, Jubilant Pharmova (BOM:530019) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,055.61, compared to a current price of ₹970.90 — trading 8% below its estimated fair value. The current E10 is ₹42.70. Jubilant Pharmova's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Jubilant Pharmova (BOM:530019), the current E10 is ₹42.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jubilant Pharmova (BOM:530019) Overvalued in 2026?

Based on GuruFocus' analysis, Jubilant Pharmova stock appears to be undervalued. The current stock price of ₹970.90 is trading 8% below its estimated GF Value™ of ₹1,055.61. GuruFocus considers Jubilant Pharmova to be Fairly Valued.

Key valuation signals for BOM:530019:

  • E10: ₹42.70
  • GF Value™: ₹1,055.61 vs. price of ₹970.90 (8% below fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the BOM:530019 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jubilant Pharmova Business Description

Other Exchanges JUBLPHARMA:India
Address 1A, Sector 16A, Noida, UP, IND, 201301
Jubilant Pharmova Ltd is an integrated pharmaceutical company. The company operates in the following segments; Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation; and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment which specializes in developing, manufacturing, commercializing, and distributing therapeutic agents in the nuclear medicine domain. Geographically, it derives a majority of its revenue from the Americas and Europe and the rest from India and the Rest of the world.
70GF Score

Get the complete analysis for BOM:530019

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹970.90
Price
₹1,055.61
GF Value